KaloCyte
KaloCyte is an artificial red blood cell developing company
KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care and is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by nearly $6M in federal awards and investor funding.
Visit website: http://www.kalocyte.com/
Details last updated 27-Oct-2019
KaloCyte News
Eternal searches of blood substitute
Medical Futurist - 26-Oct-2019
Donating blood could be the most useful thing for now because someone needs it every two seconds
Read more...